BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6776017)

  • 1. Response of plasma pancreatic and gastrointestinal hormones and growth hormone to oral and intravenous glucose and insulin hypoglycaemia in Chagas's disease.
    Long RG; Albuquerque RH; Prata A; Barnes AJ; Adrian TE; Christofides ND; Bloom SR
    Gut; 1980 Sep; 21(9):772-7. PubMed ID: 6776017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone and metabolite plasma levels after oral glucose in bulimia and healthy controls.
    Casper RC; Pandy GN; Jaspan JB; Rubenstein AH
    Biol Psychiatry; 1988 Oct; 24(6):663-74. PubMed ID: 3048427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal studies in a patient with PP-producing tumors.
    Bordi C; Sivelli R; Lampugnani R; Zanella E; Fajans SS
    Horm Metab Res; 1985 Sep; 17(9):467-70. PubMed ID: 3899891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relation between catecholamines, glucagon and pancreatic polypeptide during hypoglycaemia in man.
    Järhult J; Farnebo LO; Hamberger B; Holst J; Schwartz TW
    Acta Endocrinol (Copenh); 1981 Nov; 98(3):402-6. PubMed ID: 7027713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal hormones in anorexia nervosa.
    Alderdice JT; Dinsmore WW; Buchanan KD; Adams C
    J Psychiatr Res; 1985; 19(2-3):207-13. PubMed ID: 3900360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pirenzepine on plasma insulin, glucagon and pancreatic polypeptide levels in normal man.
    Zaccaria M; Giordano G; Pasquali C; Ragazzi E; Zeviani M; Valentini P; Scandellari C
    Eur J Clin Pharmacol; 1985; 27(6):701-5. PubMed ID: 3886397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of galanin on canine plasma glucose and gastroenteropancreatic hormone responses to oral nutrients and intravenous arginine.
    McDonald TJ; Dupre J; Greenberg GR; Tepperman F; Brooks B; Tatemoto K; Mutt V
    Endocrinology; 1986 Nov; 119(5):2340-5. PubMed ID: 2429832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity.
    Holst JJ; Schwartz TW; Lovgreen NA; Pedersen O; Beck-Nielsen H
    Int J Obes; 1983; 7(6):529-38. PubMed ID: 6360922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gastro-entero-pancreatic hormone response to fasting in obesity.
    Andrews WJ; Henry RW; Alberti KG; Buchanan KD
    Diabetologia; 1981 Nov; 21(5):440-5. PubMed ID: 7028557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut hormones in acute diarrhoea.
    Besterman HS; Christofides ND; Welsby PD; Adrian TE; Sarson DL; Bloom SR
    Gut; 1983 Jul; 24(7):665-71. PubMed ID: 6345284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic and gastrointestinal hormones in chronic pancreatitis.
    Besterman HS; Adrian TE; Bloom SR; Christofides ND; Mallinson CN; Ponti V; Lombardo L; Modigliani R; Guerin S; South M
    Digestion; 1982; 24(3):195-208. PubMed ID: 6754514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maximal stimulation of pancreatic islet B-cells, and A-cell response to arginine, in dogs with longterm pancreatic acinar atrophy.
    Meister R; Berger I; Schwille PO; Gebhardt C
    Eur J Surg; 1991 May; 157(5):333-40. PubMed ID: 1678647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic and pituitary hormonal responses to insulin-induced hypoglycaemia during muscarinic cholinergic blockade in man.
    Fisher BM; Hepburn DA; Frier BM; Morton JJ; Beastall GH; Gray CE; Buchanan KD
    Eur J Clin Invest; 1992 Sep; 22(9):614-8. PubMed ID: 1333962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic polypeptide, pancreatic glucagon and enteroglucagon in morbid obesity and following gastric bypass operation.
    Meryn S; Stein D; Straus EW
    Int J Obes; 1986; 10(1):37-42. PubMed ID: 3710688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatinoma syndrome accompanied by overproduction of pancreatic polypeptide.
    Nakanome C; Koizumi M; Fujiya H; Akai H; Toyota T; Goto Y; Kameyama J; Miyakawa K; Hanew K
    Tohoku J Exp Med; 1984 Feb; 142(2):201-10. PubMed ID: 6144197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of partial pancreatectomy, systemic hormone delivery, and duct obliteration to glucose regulation in canine pancreas. Importance in pancreas transplantation.
    van der Burg MP; Gooszen HG; Guicherit OR; Jansen JB; Frölich M; van Haastert FA; Lamers CB
    Diabetes; 1989 Sep; 38(9):1082-9. PubMed ID: 2670640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high concentration of circulating insulin suppresses the glucagon response to hypoglycemia in normal man.
    Liu D; Moberg E; Kollind M; Lins PE; Adamson U
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1123-8. PubMed ID: 1682339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic glucoregulatory hormones in cirrhosis of the liver: portal vein concentrations during intravenous glucose tolerance test and in response to a meal.
    Holst JJ; Burcharth F; Kühl C
    Diabete Metab; 1980 Jun; 6(2):117-27. PubMed ID: 6997101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for pancreatic polypeptide in the regulation of gastric emptying and short-term metabolic control.
    Schmidt PT; Näslund E; Grybäck P; Jacobsson H; Holst JJ; Hilsted L; Hellström PM
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5241-6. PubMed ID: 15998783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related reduction in glucose elimination is accompanied by reduced glucose effectiveness and increased hepatic insulin extraction in man.
    Ahrén B; Pacini G
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3350-6. PubMed ID: 9745453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.